CircRNA Synthesis Market Growth, Size, Trends Analysis - By Product & Service, By Application, By End-use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

CircRNA Synthesis Market Introduction and Overview

According to SPER market research, 'Global CircRNA Synthesis Market Size- By Product & Service, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global CircRNA Synthesis Market is predicted to reach 828.16 million by 2034 with a CAGR of 16.15%.

Circular RNA (circRNA) synthesis is the process of creating circular RNA molecules in the lab that look like naturally occurring circRNAs. CircRNAs are more stable and less susceptible to degradation than linear RNA because they form covalently closed loops with no 5' or 3' ends. These properties allow for more effective and extended protein expression, which is especially useful for gene therapy, vaccines, and cancer treatment. Typically, enzymatic ligation or chemical methods are utilised to join RNA ends during circRNA synthesis.

Restraints: There are several key barriers that may prohibit the circRNA synthesis market from increasing. High synthesis costs, which encompass design, manufacturing, and purification, pose significant financial challenges for fledgling biotech companies and smaller research centres. The technical difficulty of circRNA synthesis necessitates the use of sophisticated technologies and trained personnel, further restricting accessibility.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product & Service, By Application, By End-use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Amerigo Scientific, Applied Biological Materials Inc., BOC Sciences, Creative Biolabs, Creative Biogene, GeneCopoeia, Inc., GenScript, Guangzhou Geneseed Biotech. Co., Ltd., LGC Biosearch Technologies, and SBS Genetech

Global CircRNA Synthesis Market Segmentation:

By Product & Service: Based on the Product & Service, Global CircRNA Synthesis Market is segmented as; Reagents & Kits.

By Application: Based on the Application, Global CircRNA Synthesis Market is segmented as; Therapeutics Development.

By End Use: Based on the By End Use, Global CircRNA Synthesis Market is segmented as; Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA25174

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global CircRNA Synthesis Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global CircRNA Synthesis Market

7. Global CircRNA Synthesis Market, By Product (USD Million) 2021-2034

7.1. Reagents
7.2. Kits

8. Global CircRNA Synthesis Market, By Application (USD Million) 2021-2034

8.1. Therapeutics Development
8.2. Drug Discovery
8.3. Other Applications

9. Global CircRNA Synthesis Market, By End Use (USD Million) 2021-2034

9.1. Pharmaceutical & Biotechnology Companies
9.2. Academic & Research Institutes
9.3. Others

10. Global CircRNA Synthesis Market, (USD Million) 2021-2034

10.1. Global CircRNA Synthesis Market Size and Market Share

11. Global CircRNA Synthesis Market, By Region, (USD Million) 2021-2034

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Amerigo Scientific
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Applied Biological Materials Inc
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. BOC Sciences
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Creative Biolabs
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Creative Biogene
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. GeneCopoeia, Inc.
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. GenScript
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Guangzhou Geneseed Biotech. Co., Ltd.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. LGC Biosearch Technologies
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. SBS Genetech
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others